Health economics in drug development: efficient research to inform healthcare funding decisions

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Peter S HallDavid A Cameron

Abstract

In order to decide whether a new treatment should be used in patients, a robust estimate of efficacy and toxicity is no longer sufficient. As a result of increasing healthcare costs across the globe healthcare payers and providers now seek estimates of cost-effectiveness as well. Most trials currently being designed still only consider the need for prospective efficacy and toxicity data during the development life-cycle of a new intervention. Hence the cost-effectiveness estimates are inevitably less precise than the clinical data on which they are based. Methods based on decision theory are being developed by health economists that can contribute to the design of clinical trials in such a way that they can more effectively lead to better informed drug funding decisions on the basis of cost-effectiveness in addition to clinical outcomes. There is an opportunity to apply these techniques prospectively in the design of future clinical trials. This article describes the problems encountered by those responsible for drug reimbursement decisions as a consequence of the current drug development pathway. The potential for decision theoretic methods to help overcome these problems is introduced and potential obstacles in implementation...Continue Reading

References

Nov 1, 1996·Health Economics·K Claxton, J Posnett
Feb 10, 1998·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J C Felli, G B Hazen
Dec 9, 1998·Health Economics·M E Backhouse
Sep 18, 2001·Journal of Health Economics·K Claxton, K M Thompson
Apr 20, 2004·Medical Decision Making : an International Journal of the Society for Medical Decision Making·A E AdesK Claxton
May 25, 2004·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Fumie Yokota, Kimberly M Thompson
Jun 24, 2004·Risk Analysis : an Official Publication of the Society for Risk Analysis·Fumie Yokota, Kimberly M Thompson
Oct 23, 2004·BMJ : British Medical Journal·R S TaylorS D Sullivan
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Cynthia P IglesiasUNKNOWN NEVALAT Project Group
Apr 5, 2005·Statistics in Medicine·Andrew R Willan, Eleanor M Pinto
Feb 9, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·L AnnemansB Jolain
Sep 2, 2006·Journal of Health Economics·Alan Brennan, Samer A Kharroubi
Sep 19, 2006·Health Economics·Simon Eckermann, Andrew R Willan
Sep 26, 2006·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Elisabeth FenwickAlex Sutton
Mar 1, 2007·Health Economics·Alan Brennan, Samer A Kharroubi
Apr 6, 2007·British Medical Bulletin·Simon WalkerMark Sculpher
Jul 20, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Doug Coyle, Jeremy Oakley
Sep 1, 2007·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Alan BrennanJim Chilcott
Feb 5, 2008·BMJ : British Medical Journal·Karl ClaxtonMark J Sculpher
Feb 12, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Laura BojkeStephen Palmer
Apr 8, 2009·Journal of Clinical Epidemiology·Kevin E ThorpeKalipso Chalkidou
Apr 18, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kevin E ThorpeKalipso Chalkidou
Jan 29, 2010·Journal of the National Cancer Institute·Charlie Schmidt

❮ Previous
Next ❯

Citations

Dec 6, 2011·Journal of the National Cancer Institute·Peter S HallDavid Cameron
Nov 3, 2011·ClinicoEconomics and Outcomes Research : CEOR·Tania StafinskiChristopher McCabe
Sep 20, 2015·Applied Health Economics and Health Policy·George A K van VoornTalitha L Feenstra
Jun 29, 2014·Journal of Thrombosis and Thrombolysis·Carla RognoniNicola Lucio Liberato
Apr 5, 2015·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Hawre JalalKaren M Kuntz
Dec 12, 2018·Journal of Comparative Effectiveness Research·Daphne I LingNick Bansback

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Long-term Effects of Medical Implants
Volker AltReinhard Schnettler
Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Pei-Jung Lin, P Neumann
© 2021 Meta ULC. All rights reserved